The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Open accessAbstract
Purpose: Human papillomavirus type 16 (HPV16) infection is causing an increasing number of oropharyngeal cancers in the United States and Europe. The aim of our study was to investigate whether HPV antibodies are associated with head and neck cancer risk when measured in prediagnostic sera. Methods: We identified 638 participants with incident head and neck cancers (patients; 180 oral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers) and 300 patients with esophageal cancers as well as 1,599 comparable controls from within the European Prospective Investigation Into Cancer and Nutrition cohort. Prediagnostic plasma samples from patients (collected, on average, 6 years before diagnosis) and control participants were analyzed for antibodies against multiple proteins of HPV16 as well as HPV6, HPV11, HPV18, HPV31, HPV33, HPV45, and HPV52. Odds ratios (ORs) of cancer and 95% CIs were calculated, adjusting for potential confounders. All-cause mortality was evaluated among patients using Cox proportional hazards regression. Results: HPV16 E6 seropositivity was present in prediagnostic samples for 34.8% of patients with oropharyngeal cancer and 0.6% of controls (OR, 274; 95% CI, 110 to 681) but was not associated with other cancer sites. The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis. The all-cause mortality ratio among patients with oropharyngeal cancer was 0.30 (95% CI, 0.13 to 0.67), for patients who were HPV16 E6 seropositive compared with seronegative. Conclusion: HPV16 E6 seropositivity was present more than 10 years before diagnosis of oropharyngeal cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., & Gillison, M. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065497 · Cited by 2,692
Self-citationRiboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866
Self-citationHerrero, R. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg107 · Cited by 1,228
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,053
Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
Mork, J., Lie, A. K., Glattre, E., Clark, S., Hallmans, G., Jellum, E., Koskela, P., Møller, B., Pukkala, E., Schiller, J. T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441503 · Cited by 939
Self-citationNäsman, A., Attner, P., Hammarstedt, L., Du, J., Eriksson, M., Giraud, G., Ährlund‐Richter, S., Marklund, L., Romanitan, M., Lindquist, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24339 · Cited by 720
Waterboer, T., Sehr, P., Michael, K. M., Franceschi, S., Nieland, J. D., Joos, T. O., Templin, M. F., & Pawlita, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052381 · Cited by 594
Self-citationSuppression of non-specific binding in serological Luminex assays
Waterboer, T., Sehr, P., & Pawlita, M. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.11.008 · Cited by 279
Self-citationThe serological response to papillomaviruses
Dillner, J. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0146 · Cited by 231
Ribeiro, K. B., Levi, J. E., Pawlita, M., Koifman, S., Matos, E., Eluf-Neto, J., Wunsch-Filho, V., Curado, M. P., Shangina, O., Zaridze, D., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq249 · Cited by 186
Self-citationHeideman, D. A. M., Waterboer, T., Pawlita, M., Delis-van Diemen, P., Nindl, I., Leijte, J. A., Bonfrer, J. M. G., Horenblas, S., Meijer, C. J. L. M., & Snijders, P. J. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3182 · Cited by 166
Self-citationMeschede, W., Zumbach, K., Braspenning, J., Scheffner, M., Benítez-Bribiesca, L., Luande, J., Gissmann, L., & Pawlita, M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.475-480.1998 · Cited by 148
Self-citationClifford, G. M., Shin, H., Oh, J., Waterboer, T., Ju, Y., Vaccarella, S., Quint, W. G. V., Pawlita, M., & Franceschi, S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0349 · Cited by 144
Self-citationHong, A., Grulich, A. E., Jones, D., Lee, C. S., Garland, S. M., Dobbins, T., Clark, J. R., Harnett, G. B., Milross, C., O’Brien, C. J., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.098 · Cited by 144
Smith, E., Rubenstein, L. M., Haugen, T. H., Pawlita, M., & Turek, L. P. (2012) · Journal of Oncology · doi:10.1155/2012/571862 · Cited by 121
Self-citationSitas, F., Egger, S. J., Urban, M. I., Taylor, P. R., Abnet, C. C., Boffetta, P., O’Connell, D. L., Whiteman, D. C., Brennan, P., Malekzadeh, R., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr499 · Cited by 91
Self-citationSerum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
Anderson, K. S., Wong, J., DʼSouza, G., Riemer, A. B., Lorch, J. H., Haddad, R. I., Pai, S. I., Longtine, J. A., McClean, M. D., LaBaer, J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.171 · Cited by 71
Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients
Silins, I., Åvall-Lundqvist, E. H., Tadesse, A., Jansen, K. U., Stendahl, U., Lenner, P., Zumbach, K., Pawlita, M., Dillner, J., & Frankendal, B. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6628 · Cited by 55
Self-citation
Cited by
The molecular landscape of head and neck cancer
Leemans, C. R., Snijders, P. J. F., & Brakenhoff, R. H. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.11 · Cited by 1,395
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
Gillison, M. L., Chaturvedi, A. K., Anderson, W. F., & Fakhry, C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6995 · Cited by 1,219
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Cancer prevention from the perspective of global cancer burden patterns
Nagai, H., & Kim, Y. H. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.02.75 · Cited by 621
Epidemiology of Head and Neck Cancer
Rettig, E. M., & D’Souza, G. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.03.001 · Cited by 524
Metadata
- Authors
- Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., Sánchez, M. J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R. C., Khaw, K.-T., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Panico, S., Masala, G., Grioni, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Laurell, G., Hallmans, G., Manjer, J., Ekström, J., Skeie, G., Lund, E., Weiderpass, E., Ferrari, P., Byrnes, G., Romieu, I., Riboli, E., Hildesheim, A., Boeing, H., Pawlita, M., & Brennan, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-07-20
- Volume
- 31
- Issue
- 21
- Pages
- 2708-2715
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2148344434
- Cited by
- 335
- References
- 21
- FWCI
- 31.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.